Antimicrobial Agents Practice Questions

Q: Which class of antibiotics is primarily inactivated by extended-spectrum β-lactamases (ESBLs)?

Third-generation cephalosporins. ***Third-generation cephalosporins*** - **ESBLs** are a group of enzymes primarily known for their ability to hydrolyze and inactivate **third-generation cephalosporins** (e.g., ceftriaxone, ceftazidime) and other beta-lactam antibiotics. - This inactivation mechanism renders agents like **ceftriaxone ineffective** against bacteria producing these enzymes, leading to significant treatment challenges. *Macrolides* - **Macrolides** (e.g., azithromycin, erythromycin) act by **inhibiting bacterial protein synthesis** through binding to the 50S ribosomal subunit. - Their mechanism of action is distinct from beta-lactam antibiotics, and they are generally **not inactivated by ESBL enzymes**. *Quinolones* - **Quinolones** (e.g., ciprofloxacin, levofloxacin) primarily function by **inhibiting bacterial DNA gyrase and topoisomerase IV**, thereby preventing DNA replication. - **ESBLs do not target quinolones**; resistance to quinolones typically arises from mutations in gyrase or efflux pump mechanisms. *Aminoglycosides* - **Aminoglycosides** (e.g., gentamicin, amikacin) are bactericidal antibiotics that **bind to the 30S ribosomal subunit**, interfering with protein synthesis. - While resistance to aminoglycosides can occur through modifying enzymes, **ESBLs do not inactivate this class of antibiotics**.

Q: Which of the following antifungal agents is used in combination therapy for cryptococcal meningitis?

Flucytosine. **Flucytosine** - **Flucytosine** is commonly used in combination with **amphotericin B** for the initial treatment of **cryptococcal meningitis** [1][2][3]. - This combination therapy allows for synergy, improving efficacy and potentially reducing the dosage and toxicity of amphotericin B [1]. *Nystatin* - **Nystatin** is an antifungal agent primarily used for topical or oral treatment of **mucocutaneous candidiasis**. - It is not systemically absorbed and therefore ineffective for invasive infections like **cryptococcal meningitis**. *Terbinafine* - **Terbinafine** is an antifungal drug mainly used to treat **dermatophyte infections**, such as athlete's foot and onychomycosis [2]. - Its mechanism of action targets fungal ergosterol synthesis at an early stage, which is not suitable for treating **cryptococcal meningitis**. *Voriconazole* - **Voriconazole** is a broad-spectrum azole antifungal used for severe invasive fungal infections, including **aspergillosis** and **candidiasis** [2]. - While it has some activity against *Cryptococcus*, it is not the preferred or standard agent for initial combination therapy for **cryptococcal meningitis**, for which amphotericin B and flucytosine are typically used [2].

Q: Which oral drug combination is recommended as first-line treatment for uncomplicated malaria caused by chloroquine-resistant *P. falciparum*?

Artemether-Lumefantrine. ***Artemether-Lumefantrine*** - **Artemether-Lumefantrine (AL)** is a WHO-recommended **Artemisinin-based Combination Therapy (ACT)** and the most widely used first-line treatment for uncomplicated **chloroquine-resistant *P. falciparum* malaria**. - The combination provides **rapid parasite clearance** (artemether) and **prevents recrudescence** (lumefantrine), with excellent efficacy and tolerability. - It is administered as a **3-day oral regimen** and is suitable for use in most endemic regions. *Artesunate-Mefloquine* - While **Artesunate-Mefloquine** is also a WHO-recommended ACT and effective against chloroquine-resistant malaria, it is less commonly used than Artemether-Lumefantrine due to **mefloquine's neuropsychiatric side effects** (dizziness, anxiety, sleep disturbances). - It is primarily used in regions where other ACTs have reduced efficacy, particularly in **Southeast Asia**. *Quinine plus Doxycycline* - **Quinine plus Doxycycline** is an effective combination but is generally considered a **second-line treatment** due to quinine's **poor tolerability** and **complex 7-day dosing regimen**. - **Side effects** include **cinchonism** (tinnitus, headache, nausea) and **cardiac arrhythmias**, limiting its use as first-line therapy. - Doxycycline is contraindicated in **pregnancy** and **children under 8 years**. *Atovaquone-Proguanil* - **Atovaquone-Proguanil (Malarone)** is highly effective and well-tolerated but is **expensive** and primarily used for **prophylaxis** or treatment in **travelers** from non-endemic countries. - It is not recommended as first-line treatment in endemic regions due to **cost considerations** and limited availability.

Q: Which of the following drugs is NOT considered a first-line treatment for candidiasis?

Caspofungin. ***Caspofungin*** - Caspofungin is an **echinocandin** that, while highly effective against *Candida*, is **not typically used as initial therapy** for common candidal infections such as **oral thrush** or **vulvovaginal candidiasis**. - It is generally reserved for **invasive candidiasis** in hospitalized patients or when **azoles are ineffective or contraindicated**. - Its use is limited by **intravenous-only administration**, higher cost, and reserve status for serious infections. *Fluconazole* - **Fluconazole** is the **first-line azole antifungal** for most forms of candidiasis, including **oropharyngeal, esophageal, and vulvovaginal candidiasis**. - Its excellent **oral bioavailability**, favorable side effect profile, and proven efficacy make it the preferred initial treatment in most clinical settings. *Nystatin* - **Nystatin** is a **polyene antifungal** widely used as **first-line therapy** for **localized mucocutaneous candidiasis**, particularly **oral thrush** (as swish-and-swallow suspension) and cutaneous infections. - Its topical action, minimal systemic absorption, and excellent safety profile make it ideal for superficial candidal infections. *Amphotericin B* - **Amphotericin B** is a **broad-spectrum polyene antifungal** with potent fungicidal activity, but it is **not routinely used as first-line therapy** for most candidiasis due to significant toxicity (nephrotoxicity, infusion reactions). - While historically used for severe infections, current guidelines favor **echinocandins or azoles as first-line agents** for invasive candidiasis, with Amphotericin B reserved for resistant cases or specific clinical situations. - Its use as initial therapy is primarily considered when other agents cannot be used due to resistance or contraindications.

Q: Which of the following statements about cephalosporins is false?

Active against only gram-positive bacteria. ***Active against only gram-positive bacteria*** - This statement is **false** because later generations of cephalosporins, especially third and fourth generations, have significant activity against **gram-negative bacteria**. - While earlier generations had a stronger gram-positive spectrum, **cephalosporins** as a class are not limited to gram-positive bacteria. *Bactericidal agents* - Cephalosporins are indeed **bactericidal** agents, meaning they kill bacteria rather than just inhibiting their growth. - They achieve this by interfering with **bacterial cell wall synthesis**, specifically by binding to penicillin-binding proteins (PBPs). *Ceftriaxone is administered via injection.* - **Ceftriaxone** is a third-generation cephalosporin commonly administered via **intramuscular or intravenous injection**. - Its long half-life allows for once-daily dosing, making it a convenient option for parenteral treatment. *Third-generation cephalosporins are resistant to certain beta-lactamases from gram-negative bacteria.* - Third-generation cephalosporins were developed to have increased stability against many common **beta-lactamases produced by gram-negative bacteria**, a significant advantage over earlier generations. - This resistance improves their efficacy against a broader range of gram-negative pathogens, although some newer **extended-spectrum beta-lactamases (ESBLs)** can still inactivate them.

Q: All are used in the treatment of amoebic liver abscess except:

Diloxanide furoate. ***Diloxanide furoate*** - This drug is primarily a **luminal amebicide**, meaning it acts in the intestines to eliminate cysts and trophozoites and is used to treat **asymptomatic cyst carriers**. - It is not effective against **extraintestinal forms** of amebiasis, such as an **amebic liver abscess**, where trophozoites are found in tissues. *Metronidazole* - **Metronidazole** is the drug of choice for treating **amebic liver abscess** and other **extraintestinal amebiasis** due to its excellent tissue penetration and amebicidal activity. - It effectively kills **trophozoites** in the liver and other tissues, leading to resolution of the abscess. *Emetine* - **Emetine** (or its derivative, dehydroemetine) is a potent **tissue amebicide** and can be used in the treatment of **amebic liver abscess**, especially when metronidazole is contraindicated or ineffective. - However, its use is limited by significant **cardiotoxicity**, requiring careful monitoring. *Chloroquine* - **Chloroquine** possesses some **amebicidal activity**, particularly against trophozoites in the liver, making it useful as an adjunct or alternative in the treatment of **amebic liver abscess**. - It is often used in combination with other amebicides or in cases where metronidazole alone is insufficient.

Q: Which of the following is not typically used as a first-line treatment for Helicobacter pylori infection?

Ofloxacin. ***Ofloxacin*** - **Ofloxacin** is a **fluoroquinolone antibiotic** and is generally reserved for **second-line** or **rescue therapies** for *H. pylori* eradication due to increasing resistance and the availability of more established first-line regimens. - While fluoroquinolones can be effective, they are not typically included in standard **triple or quadruple first-line therapies** for *H. pylori* due to concerns about wider antimicrobial resistance and potential side effects when other agents are available. *Clarithromycin* - **Clarithromycin** is a key antibiotic in many **first-line triple therapy regimens** for *H. pylori* eradication, often combined with a proton pump inhibitor and amoxicillin or metronidazole. - Its effectiveness can be limited by regional **clarithromycin resistance rates**, which may necessitate alternative regimens. *Amoxicillin* - **Amoxicillin** is a commonly used antibiotic in **first-line triple therapy** for *H. pylori*, typically combined with a proton pump inhibitor and clarithromycin. - It is generally well-tolerated and effective, particularly in areas with lower rates of amoxicillin resistance. *Metronidazole* - **Metronidazole** is an important component of several **first-line *H. pylori* eradication regimens**, including classic triple therapy (when amoxicillin is not used) and bismuth-based quadruple therapy. - Its use depends on local **metronidazole resistance patterns** and patient tolerance, as some individuals experience side effects like a metallic taste or nausea.

Q: Tetracycline is used in prophylaxis of which of the following diseases?

Leptospirosis. ***Leptospirosis (Correct Answer)*** - **Doxycycline**, a tetracycline antibiotic, is the **standard prophylactic agent** for **leptospirosis**, especially for individuals with high exposure risk (travelers to endemic areas, military personnel, occupational exposure). - **Prophylactic regimen**: 200 mg once weekly during exposure and for 2 weeks after last exposure. - It helps prevent the disease by inhibiting bacterial growth before infection becomes established. *Cholera (Incorrect)* - While tetracyclines like doxycycline can be used to **treat cholera** to reduce fluid loss and duration of diarrhea, they are **not used for prophylaxis** in healthy individuals. - Prophylaxis relies on **safe water and sanitation practices**, **oral cholera vaccine**, and proper food handling—not routine antibiotic administration. *Brucellosis (Incorrect)* - **Tetracyclines** (doxycycline) are essential for the **treatment** of **brucellosis**, typically in combination with rifampicin or streptomycin for 6 weeks, due to its intracellular nature and risk of relapse. - However, they are **not routinely used for prophylaxis** against brucellosis, even in high-risk individuals. *Meningitis (Incorrect)* - **Tetracyclines are not recommended for prophylaxis of bacterial meningitis**. - Prophylaxis for close contacts of meningococcal meningitis typically involves **rifampin**, **ceftriaxone**, or **ciprofloxacin**—not tetracyclines.

Q: Maximum sterilizing action is shown by which anti-TB drug?

Rifampicin. ***Rifampicin*** - Rifampicin has the **maximum sterilizing activity** among all anti-TB drugs, killing semi-dormant and intermittently metabolizing bacilli in various tissue environments. - Its sterilizing effect is crucial for **shortening treatment duration from 12-18 months to 6 months** and preventing relapses. - Rifampicin acts on persisters that other drugs cannot eliminate, making it the most important sterilizing drug in TB therapy. *Pyrazinamide* - Pyrazinamide has **unique sterilizing activity specifically in acidic environments** (pH < 5.5) within macrophages and caseous necrotic lesions. - While highly effective in acidic conditions where other drugs work poorly, its sterilizing action is environment-specific, not the maximum overall. - Its addition to regimens allows treatment shortening from 9 months to 6 months. *Streptomycin* - Streptomycin is an **aminoglycoside** with bactericidal action against actively dividing extracellular M. tuberculosis. - It does not penetrate cells well and has minimal activity against intracellular or dormant bacilli, thus limited sterilizing action. *INH* - Isoniazid (INH) is the most potent **early bactericidal drug** against rapidly multiplying tubercle bacilli. - While highly effective at reducing bacterial load initially, it has limited activity against dormant persisters and thus less sterilizing action compared to rifampicin.

Question 1

Which class of antibiotics is primarily inactivated by extended-spectrum β-lactamases (ESBLs)?

Accepted Answer

Third-generation cephalosporins

Answer

Macrolides

Answer

Quinolones

Answer

Aminoglycosides

Question 2

Which of the following antifungal agents is used in combination therapy for cryptococcal meningitis?

Accepted Answer

Flucytosine

Answer

Nystatin

Answer

Terbinafine

Answer

Voriconazole

Question 3

Which oral drug combination is recommended as first-line treatment for uncomplicated malaria caused by chloroquine-resistant *P. falciparum*?

Accepted Answer

Artemether-Lumefantrine

Answer

Quinine plus Doxycycline

Answer

Artesunate-Mefloquine

Answer

Atovaquone-Proguanil

Question 4

Which of the following drugs is NOT considered a first-line treatment for candidiasis?

Accepted Answer

Caspofungin

Answer

Nystatin

Answer

Amphotericin B

Answer

Fluconazole

Question 5

Which of the following statements about cephalosporins is false?

Accepted Answer

Active against only gram-positive bacteria

Answer

Ceftriaxone is administered via injection.

Answer

Bactericidal agents

Answer

Third-generation cephalosporins are resistant to certain beta-lactamases from gram-negative bacteria.

Question 6

Which of the following medications is a first-line antitubercular drug used routinely in children of all age groups without significant monitoring limitations?

Accepted Answer

Pyrazinamide

Answer

Ethambutol

Answer

Streptomycin

Answer

Combination of all first-line ATT agents

Question 7

All are used in the treatment of amoebic liver abscess except:

Accepted Answer

Diloxanide furoate

Answer

Metronidazole

Answer

Emetine

Answer

Chloroquine

Question 8

Which of the following is not typically used as a first-line treatment for Helicobacter pylori infection?

Accepted Answer

Ofloxacin

Answer

Clarithromycin

Answer

Amoxicillin

Answer

Metronidazole

Question 9

Tetracycline is used in prophylaxis of which of the following diseases?

Accepted Answer

Leptospirosis

Answer

Meningitis

Answer

Brucellosis

Answer

Cholera

Question 10

Maximum sterilizing action is shown by which anti-TB drug?

Accepted Answer

Rifampicin

Answer

Pyrazinamide

Answer

Streptomycin

Answer

INH

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?